These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 26369416)

  • 21. Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
    Zhao L; Mu B; Zhou R; Cheng Y; Huang C
    Int J Rheum Dis; 2019 Apr; 22(4):686-694. PubMed ID: 30666825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
    Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.
    Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q
    Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
    Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
    Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia.
    Kseibati MO; Sharawy MH; Salem HA
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107011. PubMed ID: 33045575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.
    Zhang C; Cai R; Lazerson A; Delcroix G; Wangpaichitr M; Mirsaeidi M; Griswold AJ; Schally AV; Jackson RM
    Lung; 2019 Oct; 197(5):541-549. PubMed ID: 31392398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
    Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
    Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
    Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis.
    Song JS; Kang CM; Rhee CK; Yoon HK; Kim YK; Moon HS; Park SH
    Exp Lung Res; 2009 Dec; 35(10):817-29. PubMed ID: 19995276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.
    Garcia O; Carraro G; Turcatel G; Hall M; Sedrakyan S; Roche T; Buckley S; Driscoll B; Perin L; Warburton D
    PLoS One; 2013; 8(8):e71679. PubMed ID: 23967234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
    Howell DC; Johns RH; Lasky JA; Shan B; Scotton CJ; Laurent GJ; Chambers RC
    Am J Pathol; 2005 May; 166(5):1353-65. PubMed ID: 15855637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β.
    Ogawa H; Ledford JG; Mukherjee S; Aono Y; Nishioka Y; Lee JJ; Izumi K; Hollingsworth JW
    Respir Res; 2014 Nov; 15(1):143. PubMed ID: 25472740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective and anti-inflammatory effect of selenium nano-particles against bleomycin-induced pulmonary injury in male rats.
    Shahabi R; Anissian A; Javadmoosavi SA; Nasirinezhad F
    Drug Chem Toxicol; 2021 Jan; 44(1):92-100. PubMed ID: 31146593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
    Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE
    Respiration; 2018; 95(2):122-136. PubMed ID: 29131071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury.
    Fusco R; Siracusa R; D'Amico R; Cordaro M; Genovese T; Gugliandolo E; Peritore AF; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
    Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
    Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
    Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
    Pini A; Viappiani S; Bolla M; Masini E; Bani D
    J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis.
    Luzina IG; Lockatell V; Todd NW; Kopach P; Pentikis HS; Atamas SP
    J Pharmacol Exp Ther; 2015 Oct; 355(1):13-22. PubMed ID: 26209236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.